Atomwise Stock
Atomwise is an artificial intelligence (AI)-driven drug discovery company harnessing the power of deep learning and massive computational resources for the development of novel pharmaceuticals. Its proprietary platform, AtomNet, utilizes techniques mimicking molecular recognition to screen vast libraries of chemical compounds.
Founded: 2012
For more Atomwise stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Abraham Heifets, Ph.D. Co-Founder and CEO |
| Izhar Wallach, Ph.D. Co-Founder and CTO |
| Gavin Hirst, Ph.D. Chief Scientific Officer |
| Neely Mozaffarian, M.D., Ph.D. Chief Medical Officer |
